Tellen Bennett
Concepts (406)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries, Traumatic | 17 | 2025 | 360 | 5.080 |
Why?
| | Sepsis | 15 | 2025 | 617 | 4.180 |
Why?
| | Intensive Care Units, Pediatric | 20 | 2025 | 233 | 3.650 |
Why?
| | Intracranial Pressure | 8 | 2025 | 49 | 2.560 |
Why?
| | Brain Injuries | 9 | 2025 | 494 | 2.370 |
Why?
| | Machine Learning | 7 | 2025 | 493 | 2.080 |
Why?
| | Intracranial Hypertension | 5 | 2025 | 40 | 2.040 |
Why?
| | Child | 78 | 2025 | 21935 | 1.910 |
Why?
| | Shock, Septic | 9 | 2025 | 219 | 1.800 |
Why?
| | Hospital Mortality | 16 | 2025 | 911 | 1.710 |
Why?
| | Critical Care | 7 | 2025 | 601 | 1.690 |
Why?
| | Decision Support Systems, Clinical | 4 | 2023 | 226 | 1.560 |
Why?
| | Pediatrics | 6 | 2024 | 1101 | 1.430 |
Why?
| | Aftercare | 4 | 2024 | 208 | 1.370 |
Why?
| | Seizures | 3 | 2018 | 426 | 1.290 |
Why?
| | Critical Illness | 11 | 2025 | 811 | 1.260 |
Why?
| | Child, Preschool | 40 | 2025 | 11074 | 1.260 |
Why?
| | Infant | 38 | 2025 | 9465 | 1.230 |
Why?
| | Databases, Factual | 15 | 2023 | 1357 | 1.220 |
Why?
| | Severity of Illness Index | 7 | 2025 | 2828 | 1.210 |
Why?
| | Outpatients | 8 | 2025 | 396 | 1.170 |
Why?
| | Respiration, Artificial | 7 | 2024 | 645 | 1.160 |
Why?
| | Humans | 126 | 2025 | 137585 | 1.100 |
Why?
| | Monitoring, Physiologic | 4 | 2025 | 275 | 0.990 |
Why?
| | Retrospective Studies | 37 | 2025 | 15657 | 0.940 |
Why?
| | Blood Culture | 1 | 2025 | 23 | 0.930 |
Why?
| | Multiple Organ Failure | 8 | 2024 | 128 | 0.890 |
Why?
| | Adolescent | 43 | 2025 | 21513 | 0.890 |
Why?
| | Recovery of Function | 3 | 2019 | 653 | 0.850 |
Why?
| | Bacterial Infections | 2 | 2024 | 250 | 0.840 |
Why?
| | Bacteremia | 1 | 2025 | 214 | 0.780 |
Why?
| | Connective Tissue Diseases | 1 | 2023 | 84 | 0.750 |
Why?
| | Male | 60 | 2025 | 67762 | 0.750 |
Why?
| | Female | 64 | 2025 | 73304 | 0.740 |
Why?
| | Infant, Newborn | 18 | 2025 | 6079 | 0.730 |
Why?
| | Hospitalization | 9 | 2024 | 2199 | 0.710 |
Why?
| | Electronic Health Records | 9 | 2024 | 1069 | 0.700 |
Why?
| | Forecasting | 3 | 2021 | 389 | 0.690 |
Why?
| | Wounds and Injuries | 5 | 2019 | 758 | 0.660 |
Why?
| | Trauma Severity Indices | 3 | 2017 | 106 | 0.660 |
Why?
| | Patient Discharge | 10 | 2024 | 897 | 0.620 |
Why?
| | Health Services Research | 2 | 2019 | 404 | 0.610 |
Why?
| | Disability Evaluation | 2 | 2018 | 290 | 0.610 |
Why?
| | Specialties, Surgical | 1 | 2019 | 75 | 0.580 |
Why?
| | Tranexamic Acid | 1 | 2018 | 40 | 0.580 |
Why?
| | Algorithms | 6 | 2025 | 1704 | 0.580 |
Why?
| | Pandemics | 5 | 2023 | 1639 | 0.570 |
Why?
| | Organ Dysfunction Scores | 6 | 2024 | 48 | 0.570 |
Why?
| | Systemic Inflammatory Response Syndrome | 6 | 2024 | 93 | 0.560 |
Why?
| | Fluid Therapy | 2 | 2025 | 147 | 0.560 |
Why?
| | Hypothermia, Induced | 1 | 2018 | 80 | 0.550 |
Why?
| | Neurophysiological Monitoring | 1 | 2017 | 9 | 0.540 |
Why?
| | Child Health | 1 | 2019 | 154 | 0.530 |
Why?
| | United States | 21 | 2025 | 14841 | 0.520 |
Why?
| | Neurosurgical Procedures | 2 | 2023 | 197 | 0.510 |
Why?
| | Computer Security | 2 | 2021 | 23 | 0.510 |
Why?
| | Nurses | 1 | 2019 | 180 | 0.510 |
Why?
| | Cohort Studies | 14 | 2025 | 5742 | 0.510 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 322 | 0.500 |
Why?
| | Glasgow Coma Scale | 6 | 2025 | 186 | 0.500 |
Why?
| | Chronic Disease | 2 | 2022 | 1793 | 0.490 |
Why?
| | Phenotype | 8 | 2025 | 3196 | 0.490 |
Why?
| | Health Status Indicators | 1 | 2016 | 171 | 0.490 |
Why?
| | Patient Readmission | 2 | 2018 | 697 | 0.470 |
Why?
| | Anticonvulsants | 1 | 2017 | 217 | 0.460 |
Why?
| | Physicians | 1 | 2023 | 910 | 0.450 |
Why?
| | Medical Record Linkage | 2 | 2015 | 65 | 0.450 |
Why?
| | Medical Records Systems, Computerized | 1 | 2015 | 96 | 0.450 |
Why?
| | Child, Hospitalized | 1 | 2015 | 49 | 0.450 |
Why?
| | Spinal Injuries | 1 | 2015 | 53 | 0.450 |
Why?
| | Electroencephalography | 1 | 2017 | 423 | 0.440 |
Why?
| | Prospective Studies | 12 | 2025 | 7604 | 0.440 |
Why?
| | Hypertension | 2 | 2022 | 1295 | 0.430 |
Why?
| | Models, Biological | 1 | 2021 | 1783 | 0.420 |
Why?
| | Cervical Vertebrae | 1 | 2015 | 137 | 0.420 |
Why?
| | Mannitol | 2 | 2022 | 38 | 0.420 |
Why?
| | Saline Solution, Hypertonic | 2 | 2022 | 41 | 0.420 |
Why?
| | Supervised Machine Learning | 3 | 2023 | 17 | 0.410 |
Why?
| | Antibodies, Monoclonal | 6 | 2025 | 1430 | 0.400 |
Why?
| | Speech Therapy | 1 | 2013 | 21 | 0.400 |
Why?
| | Software | 1 | 2018 | 665 | 0.400 |
Why?
| | Decision Support Techniques | 1 | 2017 | 421 | 0.400 |
Why?
| | Macrophage Activation Syndrome | 1 | 2012 | 22 | 0.400 |
Why?
| | Adenosine Monophosphate | 2 | 2024 | 66 | 0.390 |
Why?
| | Arthritis, Juvenile | 1 | 2012 | 56 | 0.380 |
Why?
| | Alanine | 2 | 2024 | 152 | 0.380 |
Why?
| | Emergency Service, Hospital | 3 | 2021 | 2069 | 0.380 |
Why?
| | Physical Therapy Specialty | 1 | 2013 | 52 | 0.380 |
Why?
| | Injury Severity Score | 5 | 2018 | 522 | 0.380 |
Why?
| | Risk Factors | 11 | 2024 | 10388 | 0.370 |
Why?
| | Ferritins | 1 | 2011 | 64 | 0.360 |
Why?
| | Cerebrovascular Circulation | 2 | 2025 | 243 | 0.360 |
Why?
| | Occupational Therapy | 1 | 2013 | 100 | 0.350 |
Why?
| | Prognosis | 7 | 2025 | 4030 | 0.350 |
Why?
| | Brain | 2 | 2014 | 2668 | 0.350 |
Why?
| | Hospitals, Pediatric | 4 | 2018 | 508 | 0.330 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2010 | 52 | 0.330 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2012 | 242 | 0.330 |
Why?
| | Models, Statistical | 1 | 2014 | 669 | 0.330 |
Why?
| | Inpatients | 2 | 2022 | 500 | 0.320 |
Why?
| | Antibodies, Neutralizing | 4 | 2025 | 286 | 0.320 |
Why?
| | Autistic Disorder | 2 | 2023 | 204 | 0.320 |
Why?
| | Ki-67 Antigen | 2 | 2020 | 112 | 0.310 |
Why?
| | Adult | 28 | 2025 | 37929 | 0.300 |
Why?
| | Antiviral Agents | 3 | 2024 | 744 | 0.300 |
Why?
| | Length of Stay | 4 | 2023 | 1215 | 0.290 |
Why?
| | Tomography, X-Ray Computed | 2 | 2015 | 2691 | 0.280 |
Why?
| | Blood Pressure | 3 | 2025 | 1786 | 0.270 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2010 | 257 | 0.270 |
Why?
| | Proteome | 2 | 2022 | 472 | 0.260 |
Why?
| | Acute Kidney Injury | 2 | 2025 | 815 | 0.260 |
Why?
| | Infant Equipment | 1 | 2006 | 9 | 0.260 |
Why?
| | Protective Devices | 1 | 2006 | 31 | 0.260 |
Why?
| | Survival Rate | 4 | 2019 | 1972 | 0.260 |
Why?
| | Comorbidity | 2 | 2022 | 1622 | 0.260 |
Why?
| | Logistic Models | 6 | 2024 | 2074 | 0.250 |
Why?
| | Antibodies, Viral | 3 | 2024 | 625 | 0.240 |
Why?
| | Accidents, Traffic | 2 | 2006 | 190 | 0.240 |
Why?
| | Transcriptome | 2 | 2022 | 971 | 0.240 |
Why?
| | Pneumonia, Ventilator-Associated | 2 | 2016 | 53 | 0.230 |
Why?
| | Employment | 2 | 2024 | 178 | 0.230 |
Why?
| | Middle Aged | 16 | 2025 | 33479 | 0.230 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2025 | 145 | 0.230 |
Why?
| | Disease Progression | 5 | 2023 | 2757 | 0.230 |
Why?
| | Arterial Pressure | 1 | 2025 | 126 | 0.220 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2021 | 301 | 0.220 |
Why?
| | Qualitative Research | 2 | 2023 | 1386 | 0.220 |
Why?
| | Biological Science Disciplines | 1 | 2024 | 17 | 0.220 |
Why?
| | Knowledge Bases | 1 | 2024 | 27 | 0.220 |
Why?
| | Health Care Rationing | 1 | 2024 | 59 | 0.220 |
Why?
| | Accelerometry | 1 | 2024 | 103 | 0.210 |
Why?
| | Pattern Recognition, Automated | 1 | 2024 | 73 | 0.210 |
Why?
| | Wearable Electronic Devices | 1 | 2024 | 53 | 0.210 |
Why?
| | Aged | 12 | 2025 | 23961 | 0.200 |
Why?
| | Noninvasive Ventilation | 1 | 2024 | 51 | 0.200 |
Why?
| | Microscopy | 2 | 2021 | 152 | 0.200 |
Why?
| | Heart Failure | 3 | 2023 | 2236 | 0.190 |
Why?
| | Data Collection | 4 | 2022 | 673 | 0.190 |
Why?
| | Lower Extremity | 1 | 2006 | 427 | 0.190 |
Why?
| | ROC Curve | 3 | 2024 | 554 | 0.190 |
Why?
| | Brain Diseases | 1 | 2023 | 141 | 0.190 |
Why?
| | Problem Behavior | 1 | 2023 | 102 | 0.190 |
Why?
| | Quality of Life | 2 | 2024 | 2892 | 0.180 |
Why?
| | Vital Signs | 1 | 2022 | 43 | 0.180 |
Why?
| | Homeostasis | 1 | 2025 | 621 | 0.180 |
Why?
| | Blood | 1 | 2022 | 107 | 0.180 |
Why?
| | Fractures, Bone | 1 | 2006 | 380 | 0.180 |
Why?
| | Creatine | 1 | 2001 | 57 | 0.180 |
Why?
| | Blood Pressure Determination | 1 | 2022 | 157 | 0.180 |
Why?
| | Mobile Applications | 1 | 2024 | 183 | 0.180 |
Why?
| | Myocarditis | 1 | 2022 | 100 | 0.180 |
Why?
| | Ventricular Pressure | 1 | 2001 | 48 | 0.180 |
Why?
| | Young Adult | 8 | 2024 | 13209 | 0.180 |
Why?
| | Hydroxychloroquine | 1 | 2021 | 58 | 0.180 |
Why?
| | Respiratory Insufficiency | 1 | 2024 | 318 | 0.180 |
Why?
| | Heart Arrest | 1 | 2025 | 339 | 0.180 |
Why?
| | Global Health | 1 | 2024 | 386 | 0.180 |
Why?
| | Veins | 1 | 2001 | 63 | 0.170 |
Why?
| | Age Distribution | 1 | 2022 | 392 | 0.170 |
Why?
| | Reproducibility of Results | 6 | 2024 | 3284 | 0.170 |
Why?
| | Survivors | 2 | 2022 | 493 | 0.170 |
Why?
| | Morbidity | 1 | 2022 | 324 | 0.170 |
Why?
| | Artificial Intelligence | 1 | 2024 | 279 | 0.170 |
Why?
| | Policy Making | 2 | 1998 | 98 | 0.170 |
Why?
| | Common Data Elements | 1 | 2020 | 14 | 0.170 |
Why?
| | Washington | 2 | 2011 | 156 | 0.170 |
Why?
| | Focus Groups | 1 | 2023 | 522 | 0.170 |
Why?
| | Early Diagnosis | 1 | 2022 | 242 | 0.170 |
Why?
| | Body Temperature | 1 | 2001 | 222 | 0.170 |
Why?
| | Intersectoral Collaboration | 1 | 2021 | 60 | 0.170 |
Why?
| | Monitoring, Ambulatory | 1 | 2001 | 87 | 0.170 |
Why?
| | Acute Lung Injury | 1 | 2023 | 287 | 0.170 |
Why?
| | Interferons | 1 | 2022 | 202 | 0.170 |
Why?
| | Physical Exertion | 1 | 2001 | 215 | 0.170 |
Why?
| | Risk Assessment | 4 | 2024 | 3457 | 0.170 |
Why?
| | Databases, Genetic | 1 | 2021 | 237 | 0.160 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2021 | 560 | 0.160 |
Why?
| | Hypoxia | 2 | 2024 | 1112 | 0.160 |
Why?
| | Data Interpretation, Statistical | 2 | 2018 | 363 | 0.160 |
Why?
| | Hemodynamics | 2 | 2001 | 1113 | 0.160 |
Why?
| | Neurosurgeons | 1 | 2019 | 19 | 0.160 |
Why?
| | Terminology as Topic | 2 | 1998 | 216 | 0.160 |
Why?
| | Acute Disease | 1 | 2022 | 1007 | 0.160 |
Why?
| | Registries | 2 | 2018 | 2035 | 0.160 |
Why?
| | Dexamethasone | 1 | 2021 | 368 | 0.150 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2023 | 293 | 0.150 |
Why?
| | Medicine | 1 | 2020 | 121 | 0.150 |
Why?
| | Maternal Mortality | 1 | 1999 | 46 | 0.150 |
Why?
| | Social Determinants of Health | 1 | 2023 | 267 | 0.150 |
Why?
| | Information Dissemination | 1 | 2021 | 218 | 0.150 |
Why?
| | Abortion, Legal | 1 | 1999 | 24 | 0.150 |
Why?
| | Regression Analysis | 2 | 2017 | 1024 | 0.150 |
Why?
| | Journalism, Medical | 1 | 1998 | 6 | 0.150 |
Why?
| | Biomarkers | 3 | 2025 | 4149 | 0.150 |
Why?
| | Critical Care Nursing | 1 | 2019 | 51 | 0.150 |
Why?
| | Programming Languages | 1 | 2018 | 26 | 0.150 |
Why?
| | Follow-Up Studies | 4 | 2017 | 5131 | 0.140 |
Why?
| | Maternal-Child Health Centers | 1 | 1997 | 9 | 0.140 |
Why?
| | Immunohistochemistry | 2 | 2020 | 1738 | 0.140 |
Why?
| | Metabolome | 1 | 2021 | 350 | 0.140 |
Why?
| | National Health Programs | 1 | 1997 | 23 | 0.140 |
Why?
| | User-Computer Interface | 1 | 2019 | 159 | 0.140 |
Why?
| | Anxiety | 1 | 2025 | 1035 | 0.140 |
Why?
| | Birth Rate | 1 | 1997 | 30 | 0.140 |
Why?
| | Family Planning Services | 1 | 1999 | 92 | 0.140 |
Why?
| | Censuses | 1 | 1997 | 31 | 0.140 |
Why?
| | Editorial Policies | 1 | 1998 | 52 | 0.140 |
Why?
| | Intensive Care Units | 2 | 2023 | 827 | 0.140 |
Why?
| | Pregnancy Rate | 1 | 1997 | 65 | 0.140 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2025 | 249 | 0.140 |
Why?
| | Prejudice | 1 | 1997 | 73 | 0.130 |
Why?
| | Caregivers | 1 | 2024 | 877 | 0.130 |
Why?
| | Multivariate Analysis | 3 | 2017 | 1509 | 0.130 |
Why?
| | Pregnancy in Adolescence | 1 | 1997 | 83 | 0.130 |
Why?
| | Hyperlipoproteinemia Type I | 1 | 2016 | 6 | 0.130 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2019 | 267 | 0.130 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 2016 | 16 | 0.130 |
Why?
| | Developing Countries | 1 | 1999 | 307 | 0.130 |
Why?
| | Magnetic Resonance Imaging | 2 | 2025 | 3566 | 0.130 |
Why?
| | Cause of Death | 2 | 2018 | 434 | 0.130 |
Why?
| | Oxygen | 1 | 2001 | 931 | 0.130 |
Why?
| | Pneumonia | 1 | 2022 | 639 | 0.120 |
Why?
| | Autism Spectrum Disorder | 1 | 2021 | 395 | 0.120 |
Why?
| | Trauma Centers | 2 | 2016 | 421 | 0.120 |
Why?
| | Interviews as Topic | 1 | 2019 | 786 | 0.120 |
Why?
| | Propensity Score | 1 | 2017 | 294 | 0.120 |
Why?
| | Hyperlipidemias | 1 | 2016 | 120 | 0.120 |
Why?
| | Cell Nucleus | 1 | 2019 | 620 | 0.120 |
Why?
| | Medical Staff, Hospital | 1 | 2016 | 83 | 0.120 |
Why?
| | Abortion, Induced | 1 | 1997 | 105 | 0.120 |
Why?
| | Retinal Diseases | 1 | 2016 | 91 | 0.120 |
Why?
| | Treatment Outcome | 5 | 2024 | 10811 | 0.120 |
Why?
| | Comparative Effectiveness Research | 1 | 2016 | 152 | 0.120 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 1946 | 0.120 |
Why?
| | Organizational Culture | 1 | 2016 | 148 | 0.110 |
Why?
| | Military Personnel | 1 | 2001 | 544 | 0.110 |
Why?
| | Women's Health | 1 | 1997 | 372 | 0.110 |
Why?
| | Hospitals, High-Volume | 1 | 2014 | 44 | 0.110 |
Why?
| | Area Under Curve | 1 | 2014 | 314 | 0.100 |
Why?
| | Rural Population | 1 | 1997 | 563 | 0.100 |
Why?
| | Exercise | 1 | 2024 | 2057 | 0.100 |
Why?
| | Mass Screening | 1 | 2021 | 1287 | 0.100 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 1998 | 1329 | 0.100 |
Why?
| | Proportional Hazards Models | 2 | 2017 | 1266 | 0.100 |
Why?
| | Patient Safety | 1 | 2016 | 314 | 0.100 |
Why?
| | Deglutition | 1 | 2013 | 72 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2021 | 1313 | 0.100 |
Why?
| | Cyclophosphamide | 1 | 2012 | 247 | 0.090 |
Why?
| | Mycophenolic Acid | 1 | 2012 | 117 | 0.090 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1809 | 0.090 |
Why?
| | Time Factors | 4 | 2019 | 6828 | 0.090 |
Why?
| | Cyclosporine | 1 | 2012 | 268 | 0.090 |
Why?
| | Medical Audit | 1 | 2011 | 78 | 0.090 |
Why?
| | Datasets as Topic | 2 | 2022 | 121 | 0.090 |
Why?
| | Quality of Health Care | 1 | 2016 | 642 | 0.090 |
Why?
| | Gastrostomy | 1 | 2012 | 117 | 0.090 |
Why?
| | Tracheostomy | 1 | 2012 | 133 | 0.080 |
Why?
| | Case-Control Studies | 3 | 2023 | 3556 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2021 | 7635 | 0.080 |
Why?
| | Consensus | 2 | 2024 | 683 | 0.080 |
Why?
| | Patient Transfer | 1 | 2011 | 176 | 0.080 |
Why?
| | Interleukin-1 | 1 | 2012 | 965 | 0.070 |
Why?
| | Age Factors | 3 | 2014 | 3295 | 0.070 |
Why?
| | Gestational Age | 1 | 2010 | 910 | 0.070 |
Why?
| | Guideline Adherence | 1 | 2011 | 556 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2531 | 0.060 |
Why?
| | Research | 2 | 1999 | 451 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2025 | 5778 | 0.060 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 48 | 0.060 |
Why?
| | Neurofilament Proteins | 1 | 2025 | 52 | 0.060 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2025 | 100 | 0.060 |
Why?
| | Sepsis-Associated Encephalopathy | 1 | 2024 | 1 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2021 | 2844 | 0.050 |
Why?
| | Incidence | 1 | 2010 | 2804 | 0.050 |
Why?
| | United States Food and Drug Administration | 1 | 2024 | 208 | 0.050 |
Why?
| | Colorado | 2 | 2024 | 4565 | 0.050 |
Why?
| | Respiration | 1 | 2024 | 199 | 0.050 |
Why?
| | Heart Rate | 2 | 2025 | 822 | 0.050 |
Why?
| | Health Facilities | 1 | 2023 | 84 | 0.050 |
Why?
| | Semicircular Canals | 1 | 1982 | 23 | 0.050 |
Why?
| | Ritonavir | 1 | 2023 | 74 | 0.050 |
Why?
| | Streptococcal Infections | 1 | 2024 | 151 | 0.050 |
Why?
| | Immunization, Passive | 1 | 2022 | 90 | 0.050 |
Why?
| | Health Insurance Portability and Accountability Act | 1 | 2022 | 13 | 0.050 |
Why?
| | Urban Population | 1 | 2025 | 479 | 0.050 |
Why?
| | International Classification of Diseases | 1 | 2023 | 135 | 0.050 |
Why?
| | Sinusitis | 1 | 2024 | 221 | 0.050 |
Why?
| | Biochemical Phenomena | 1 | 2001 | 10 | 0.050 |
Why?
| | Intelligence Tests | 1 | 2021 | 57 | 0.050 |
Why?
| | Data Accuracy | 1 | 2022 | 65 | 0.050 |
Why?
| | Treatment Failure | 1 | 2022 | 356 | 0.050 |
Why?
| | Analysis of Variance | 2 | 2001 | 1316 | 0.040 |
Why?
| | Time | 1 | 2001 | 83 | 0.040 |
Why?
| | Access to Information | 1 | 2021 | 49 | 0.040 |
Why?
| | Health Policy | 1 | 2024 | 388 | 0.040 |
Why?
| | Pregnancy | 3 | 1999 | 6763 | 0.040 |
Why?
| | Health Resources | 1 | 2022 | 120 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2023 | 405 | 0.040 |
Why?
| | Government Regulation | 1 | 2021 | 54 | 0.040 |
Why?
| | Ethics Committees, Research | 1 | 2021 | 42 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2024 | 956 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 76 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2021 | 128 | 0.040 |
Why?
| | Data Mining | 1 | 2021 | 116 | 0.040 |
Why?
| | Respiratory Tract Infections | 1 | 2024 | 390 | 0.040 |
Why?
| | Attention | 1 | 2023 | 427 | 0.040 |
Why?
| | Abbreviated Injury Scale | 1 | 2019 | 22 | 0.040 |
Why?
| | Women, Working | 1 | 1999 | 12 | 0.040 |
Why?
| | Delphi Technique | 1 | 2020 | 280 | 0.040 |
Why?
| | Database Management Systems | 1 | 1999 | 51 | 0.040 |
Why?
| | Ethics | 1 | 1998 | 10 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2023 | 1289 | 0.040 |
Why?
| | South Africa | 1 | 1999 | 222 | 0.040 |
Why?
| | Emotions | 1 | 2023 | 548 | 0.040 |
Why?
| | Southeastern United States | 1 | 1997 | 32 | 0.040 |
Why?
| | North Carolina | 1 | 1997 | 110 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 2021 | 496 | 0.030 |
Why?
| | Patient Admission | 1 | 2019 | 197 | 0.030 |
Why?
| | Body Composition | 1 | 2001 | 684 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2022 | 740 | 0.030 |
Why?
| | Neuroendocrine Tumors | 1 | 2019 | 116 | 0.030 |
Why?
| | United Kingdom | 1 | 1998 | 318 | 0.030 |
Why?
| | Biomedical Research | 1 | 2023 | 692 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2021 | 752 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2001 | 1993 | 0.030 |
Why?
| | Fundus Oculi | 1 | 2016 | 65 | 0.030 |
Why?
| | Lipoprotein Lipase | 1 | 2016 | 59 | 0.030 |
Why?
| | Metabolomics | 1 | 2021 | 678 | 0.030 |
Why?
| | Health Care Surveys | 1 | 1997 | 565 | 0.030 |
Why?
| | Remission Induction | 1 | 2016 | 288 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 1997 | 275 | 0.030 |
Why?
| | Odds Ratio | 2 | 2014 | 1070 | 0.030 |
Why?
| | Vaccination | 1 | 2024 | 1381 | 0.030 |
Why?
| | Pancreatitis | 1 | 2016 | 134 | 0.030 |
Why?
| | Parents | 1 | 2023 | 1347 | 0.030 |
Why?
| | Health Education | 1 | 1997 | 341 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 1111 | 0.030 |
Why?
| | Coroners and Medical Examiners | 1 | 1994 | 8 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1774 | 0.030 |
Why?
| | Death Certificates | 1 | 1994 | 30 | 0.030 |
Why?
| | Hospitals, Low-Volume | 1 | 2014 | 22 | 0.030 |
Why?
| | Receptors, Pituitary Hormone-Regulating Hormone | 1 | 1993 | 8 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2014 | 144 | 0.030 |
Why?
| | Receptors, Neuropeptide | 1 | 1993 | 12 | 0.030 |
Why?
| | Risk Adjustment | 1 | 2014 | 78 | 0.030 |
Why?
| | Cognition | 1 | 2021 | 1153 | 0.030 |
Why?
| | Societies, Medical | 1 | 1997 | 820 | 0.030 |
Why?
| | Program Evaluation | 1 | 1997 | 898 | 0.030 |
Why?
| | DNA, Complementary | 1 | 1993 | 272 | 0.020 |
Why?
| | Cross Infection | 1 | 2015 | 256 | 0.020 |
Why?
| | Public Health | 1 | 1997 | 588 | 0.020 |
Why?
| | Utah | 1 | 2011 | 69 | 0.020 |
Why?
| | Sex Factors | 2 | 2014 | 2071 | 0.020 |
Why?
| | Decision Making | 1 | 1998 | 900 | 0.020 |
Why?
| | Pancreatic Neoplasms | 1 | 2019 | 938 | 0.020 |
Why?
| | Swine | 1 | 1993 | 775 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1325 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 431 | 0.020 |
Why?
| | Population Surveillance | 1 | 1994 | 482 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 530 | 0.020 |
Why?
| | Goals | 1 | 2011 | 170 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 1997 | 986 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2992 | 0.020 |
Why?
| | Triage | 1 | 2011 | 222 | 0.020 |
Why?
| | Quality Indicators, Health Care | 1 | 2011 | 307 | 0.020 |
Why?
| | Pyridoxine | 1 | 1988 | 36 | 0.020 |
Why?
| | Premenstrual Syndrome | 1 | 1988 | 34 | 0.020 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 1988 | 195 | 0.020 |
Why?
| | Hemorrhage | 1 | 1988 | 722 | 0.010 |
Why?
| | Physical Stimulation | 1 | 1982 | 65 | 0.010 |
Why?
| | Therapeutic Irrigation | 1 | 1982 | 77 | 0.010 |
Why?
| | Reflex | 1 | 1982 | 68 | 0.010 |
Why?
| | Nausea | 1 | 1982 | 111 | 0.010 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 1999 | 14 | 0.010 |
Why?
| | Nutrition Surveys | 1 | 1999 | 266 | 0.010 |
Why?
| | Cattle | 1 | 1999 | 984 | 0.010 |
Why?
| | Iowa | 1 | 1994 | 30 | 0.010 |
Why?
| | Receptors, Vasoactive Intestinal Peptide | 1 | 1993 | 4 | 0.010 |
Why?
| | Receptors, Calcitonin | 1 | 1993 | 3 | 0.010 |
Why?
| | Growth Hormone-Releasing Hormone | 1 | 1993 | 24 | 0.010 |
Why?
| | Receptors, Gastrointestinal Hormone | 1 | 1993 | 9 | 0.010 |
Why?
| | Homicide | 1 | 1994 | 69 | 0.010 |
Why?
| | Cell Line, Transformed | 1 | 1993 | 145 | 0.010 |
Why?
| | Bias | 1 | 1994 | 218 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1993 | 343 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1993 | 385 | 0.010 |
Why?
| | Cyclic AMP | 1 | 1993 | 234 | 0.010 |
Why?
| | Species Specificity | 1 | 1993 | 585 | 0.010 |
Why?
| | Prevalence | 1 | 1999 | 2734 | 0.010 |
Why?
| | Accidental Falls | 1 | 1994 | 196 | 0.010 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 1993 | 220 | 0.010 |
Why?
| | Transfection | 1 | 1993 | 945 | 0.010 |
Why?
| | Base Sequence | 1 | 1993 | 2181 | 0.000 |
Why?
| | Amino Acid Sequence | 1 | 1993 | 2139 | 0.000 |
Why?
| | Captopril | 1 | 1988 | 11 | 0.000 |
Why?
| | Drug Evaluation | 1 | 1988 | 84 | 0.000 |
Why?
| | Arginine Vasopressin | 1 | 1988 | 44 | 0.000 |
Why?
| | Molecular Sequence Data | 1 | 1993 | 2900 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1988 | 362 | 0.000 |
Why?
| | Animals | 3 | 1999 | 36940 | 0.000 |
Why?
| | Hypotension | 1 | 1988 | 122 | 0.000 |
Why?
| | Protein Binding | 1 | 1993 | 2224 | 0.000 |
Why?
| | Suicide | 1 | 1994 | 656 | 0.000 |
Why?
| | Drug Therapy, Combination | 1 | 1988 | 1066 | 0.000 |
Why?
| | Gene Expression Regulation | 1 | 1993 | 2607 | 0.000 |
Why?
| | Rats | 1 | 1988 | 5647 | 0.000 |
Why?
|
|
Bennett's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|